I-many Strengthens Executive Management Team; Former Accenture Managing Partner, David Blumberg, to Lead I-many's Professional Services and Client Support Organizations as Executive Vice President of Fulfillment Services

Business Wire, May 18, 2006

EDISON, N.J. -- I-many, Inc. (NASDAQ:IMNY), the leading provider of advanced Enterprise Contract Management (ECM) solutions for managing corporate commitments, today announced David Blumberg has joined I-many as Executive Vice President of Fulfillment Services. In this new position, Blumberg will be responsible for all professional services, as well as customer support and sustaining engineering functions. He will also be responsible for formulating and directing I-many's marketing strategies in its Life Sciences and Healthcare business line.

Blumberg comes to I-many from Accenture - the $16 billion global management consulting, technology services and outsourcing company - where he was a managing partner. During his 15 years at Accenture, Blumberg rose from consultant to a number of senior management positions, where he served as the lead partner for the pharmaceutical and medical products practice, global account manager for one of Accenture's "Diamond" pharmaceutical accounts, and oversaw Accenture's global pharmaceutical and medical products CRM business. He was previously with IBM and General Electric, and earned his MBA from the Wharton School of the University of Pennsylvania and BS in mechanical engineering from Ohio State University.

"David's extensive experience and high level responsibility across a broad base of industries, on both the sell-side and buy-side of contracting, brings important experience, capability, and insight to I-many," notes John A. Rade, chairman and interim president & CEO of I-many. "As we expand our footprint and grow aggressively in the burgeoning Enterprise Contract Lifecycle Management space, the addition of David to our executive management team will help us both scale and deliver the high quality services our customers require. We look forward to realizing his valuable contribution to I-many in the months and years to come."

Added Rade, "Recognizing that the Life Sciences and Healthcare segment of our business is an important platform for growth, we want to provide additional focus and direction to our initiatives and strategies in this area. To address this, David will have an additional role as lead for the Healthcare and Life Sciences market. He will work closely with our sales and marketing, and product management and development organizations, providing marketing input, product direction, and go-to market strategies."

Commented Blumberg, "I-many boasts a great tradition of providing the best-of-class solutions and services, and I'm committed to carrying this forward. It also presents a tremendous growth story, with this year emerging as a positive turning point with the rolling out of new and updated applications based on the new ECMF platform. As we expand I-many's product line and market reach, our overriding objective will be to service our clients seamlessly and effectively, while increasing the quality of the services we provide. This effort will be especially important as we further develop our relationships in the Healthcare and Life Sciences industries."

About I-many

I-many (NASDAQ:IMNY) is the leading provider of advanced Enterprise Contract Management solutions for managing corporate commitments. Designed to extend beyond the traditional contract management capabilities, I-many ContractSphere(R) offers an end-to-end solution, from pre-contract processes and contract management to transaction compliance. Ultimately, this provides companies with the visibility and control needed to manage any type of commitment - from contracts and obligations to payments and collections. The result is increased revenue, minimized risk and dramatically reduced operating costs, which deliver improved profitability with hard return on investment. More than 280 customers across 21 industries worldwide have implemented and realized the value of I-many business solutions. For more information, please visit www.imany.com.

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include: the risk of unforeseen technical or practical impediments to planned software development, which could affect the company's product release timetable; the inherent risks of large software implementation projects, which can cause customer disagreements that could affect I-many's ability to collect both services and license revenue, whether recognized or deferred; the possibility that customers could cancel maintenance and support services at the time of annual renewal, which could decrease I-many's base of recurring revenue; the possibility that current economic conditions will deteriorate; the possibility that extraordinary events outside the company's control could extend the length of the sales cycle for the company's products or make the market for the company's products more unpredictable; the risk that the company's historical dependence on the life sciences market will continue; the risk that the company will not be successful in opening new markets for its products; and other risk factors set forth from time to time in the company's filings with the Securities and Exchange Commission.